Clinical Trial Update: Ascorbic Acid Treatment in CMT1A Trial (AATIC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ascorbic acid in Charcot-Marie-Tooth disease (CMT1A) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Charcot-marie-tooth Disease
• Hereditary Motor and Sensory Neuropathies

Drugs mentioned

• Ascorbic acid (Vitamin C)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Charcot-Marie-Tooth Disease, Hereditary Motor and Sensory Neuropathies | Phase 2 | Status: COMPLETED